Cardiology http://www.globalpost.com/taxonomy/term/38645/all en Niacin therapy unhelpful, occasionally harmful: study http://www.globalpost.com/dispatch/news/afp/130309/niacin-therapy-unhelpful-occasionally-harmful-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.</p> <p>Niacin, also known as vitamin B3, has for years been widely prescribed to lower "bad" LDL cholesterol and raise levels of "good" HDL cholesterol.</p> <p>The link between high levels of LDL cholesterol and heart disease is well-documented, and doctors work to mitigate that risk with diet and lifestyle changes as well as a variety of medications. </p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130309/niacin-therapy-unhelpful-occasionally-harmful-study" target="_blank">read more</a></p> Cardiology Chemistry Disaster Entertainment Health Medicine niacin Technology AFP Sat, 09 Mar 2013 20:00:55 +0000 5778372 at http://www.globalpost.com Korean diet-US study http://www.globalpost.com/dispatch/news/yonhap-news-agency/130522/korean-diet-us-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Yonhap News Agency </div> </div> </div> <!--paging_filter--><p>SEOUL, May 23 (Yonhap) -- A joint research of South Korea and the United States has proven the effectiveness of a Korean diet in lowering cholesterol and reducing the risks of contracting related health issues such as diabetes and cardiac disorders, a report showed Thursday.</p> <p>According to the report from the Rural Development Administration, the joint research with the U.S. Department of Agriculture (USDA) has shown that a Korean diet, or Hanshik in Korean, was even more effective than the USDA dietary guidelines for Americans (DGA) in lowering cholesterol levels.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://english.yonhapnews.co.kr" class="button wire yonhap"></a></p> <p><span>Copyright Yonhap News Agency, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/yonhap-news-agency/130522/korean-diet-us-study" target="_blank">read more</a></p> Cardiology Health Lipoproteins Technology Yonhap News Agency Thu, 23 May 2013 02:15:03 +0000 5844330 at http://www.globalpost.com Isis shares jump after experimental drug cuts blood fat http://www.globalpost.com/dispatch/news/thomson-reuters/130624/isis-shares-jump-after-experimental-drug-cuts-blood-fat <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>(Reuters) - Shares of Isis Pharmaceuticals Inc &lt;ISIS.O&gt; rose as much as 24 percent after the drugmaker said its experimental drug reduced triglycerides, a type of fat, in blood and increased the level of "good" cholesterol.</p> <p>The results were "well beyond expectations and suggest an unprecedented treatment benefit in type 2 diabetics with (high cholesterol levels)," BMO Capital Markets analyst Jim Birchenough said.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130624/isis-shares-jump-after-experimental-drug-cuts-blood-fat" target="_blank">read more</a></p> Business Cardiology Chemistry Lipoproteins Technology Thomson Reuters Mon, 24 Jun 2013 19:33:02 +0000 5866111 at http://www.globalpost.com B.C. girl youngest in the world to have heart pump put in her chest http://www.globalpost.com/dispatch/news/the-canadian-press/130801/bc-girl-youngest-the-world-have-heart-pump-put-her-chest <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>EDMONTON - Muskaan Grewal didn't know the little motor whirring inside her chest, keeping her alive, was like a medical medal of honour.</p> <p>Last September, when she was just five years old, the brown-haired girl with the toothy grin became the youngest person in the world to receive a special type of artificial heart called a Ventricular Assist Device, or VAD.</p> <p>All she knew was that the invisible machine was keeping her out of the hospital and giving her enough energy to ride a bike and go to school "like a little normal kid."</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.globalpost.com/terms-use#cp">Copyright 2013 Canadian Press.</a></p> <p>All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.</p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130801/bc-girl-youngest-the-world-have-heart-pump-put-her-chest" target="_blank">read more</a></p> Cardiology Implants Medicine The Canadian Press Thu, 01 Aug 2013 18:32:47 +0000 5900249 at http://www.globalpost.com Cardiovascular Systems gets nod for new heart device http://www.globalpost.com/dispatch/news/thomson-reuters/131022/cardiovascular-systems-gets-nod-new-heart-device <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>(Reuters) - Cardiovascular Systems Inc received U.S. Food and Drug Administration approval to start selling its heart device to treat severe calcium deposits in coronary arteries, sending its shares up as much as 23 percent.</p> <p>The device, Diamondback 360 Coronary Orbital Atherectomy System, will be launched immediately after the FDA's marketing approval, the company said on Tuesday.</p> <p>Plaque build up, including calcium deposits, in arteries reduces blood supply to the heart, leading to coronary artery disease.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/131022/cardiovascular-systems-gets-nod-new-heart-device" target="_blank">read more</a></p> Cardiology Circulatory system Medicine Thomson Reuters Tue, 22 Oct 2013 17:17:39 +0000 5967675 at http://www.globalpost.com Medtronic heart valve found to reduce death, stroke rate http://www.globalpost.com/dispatch/news/thomson-reuters/131029/medtronic-heart-valve-reduces-death-stroke-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Susan Kelly</p> <p>(Reuters) - Medtronic Inc's CoreValve heart valve implant significantly lowered death and stroke rates in frail, elderly patients with severe aortic stenosis who were considered too ill for surgery, according to data from a late-stage clinical trial.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/131029/medtronic-heart-valve-reduces-death-stroke-study" target="_blank">read more</a></p> Cardiac surgery Cardiology Medicine Medtronic Inc Thomson Reuters Tue, 29 Oct 2013 19:16:34 +0000 5974353 at http://www.globalpost.com Higher clot risk seen with Thoratec heart pump: study http://www.globalpost.com/dispatch/news/thomson-reuters/131127/clot-risk-higher-previously-seen-thoratec-heart-pump-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Bill Berkrot</p> <p>(Reuters) - Researchers have found a higher rate of dangerous blood clots in patients who received Thoratec Corp's HeartMate II heart pump than had been seen in clinical trials or prior experience, according to a study published on Wednesday.</p> <p>They also found that when blood clots do develop, they are occurring closer to the time of HeartMate implantation than had been previously observed. The findings were reported in the New England Journal of Medicine.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/131127/clot-risk-higher-previously-seen-thoratec-heart-pump-study" target="_blank">read more</a></p> Cardiology Interventional cardiology Medicine Thomson Reuters Thu, 28 Nov 2013 01:16:28 +0000 6002207 at http://www.globalpost.com Amgen cholesterol drug succeeds in late-stage trial http://www.globalpost.com/dispatch/news/thomson-reuters/131219/amgen-cholesterol-drug-succeeds-late-stage-trial <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>(Reuters) - Amgen Inc said its closely watched experimental cholesterol drug succeeded in reducing the level of bad cholesterol in the blood, compared to a placebo, in a late-stage trial.</p> <p>The data was consistent with the results from a large mid-stage trial that showed the drug, evolocumab, lowered LDL cholesterol by 52 percent after one year of treatment.</p> <p>Evolocumab belongs to class of drugs called PCSK9 inhibitors, which work by blocking a protein that prevents the liver from removing LDL cholesterol from blood.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/131219/amgen-cholesterol-drug-succeeds-late-stage-trial" target="_blank">read more</a></p> Cardiology Lipoproteins Low-density lipoprotein Thomson Reuters Thu, 19 Dec 2013 18:04:38 +0000 6024815 at http://www.globalpost.com French firm starts human trials of artificial heart http://www.globalpost.com/dispatch/news/afp/131220/french-firm-starts-human-trials-artificial-heart-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>French biomedical firm Carmat said on Friday it had begun the first human trial of its prototype artificial heart, which aims at overcoming shortages of organs available for transplant.</p> <p>The implant operation, which took place on Wednesday at the Georges Pompidou Hospital in Paris, "went satisfactorily," it said in a statement.</p> <p>The patient, whom it did not name, is in intensive care, "is conscious and speaking to relatives," Carmat said, adding that it was too early to draw wider conclusions about the operation.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/131220/french-firm-starts-human-trials-artificial-heart-0" target="_blank">read more</a></p> Cardiology Implants Medicine AFP Fri, 20 Dec 2013 18:37:01 +0000 6025996 at http://www.globalpost.com France's Carmat implants its first artificial heart in human http://www.globalpost.com/dispatch/news/thomson-reuters/131220/frances-carmat-implants-first-artificial-heart-human <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Natalie Huet</p> <p>PARIS (Reuters) - France's Carmat said on Friday it had carried out its first implant of an artificial heart that can beat for up to five years, adding that the operation had gone smoothly.</p> <p>The implant operation was performed on Wednesday at the Georges Pompidou European Hospital in Paris, the biomedical firm said in a statement. It said that the male patient was awake and talking and he was being monitored in the intensive care unit.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/131220/frances-carmat-implants-first-artificial-heart-human" target="_blank">read more</a></p> Cardiology Carmat Health Implants Labor Medicine Social Issues Thomson Reuters Fri, 20 Dec 2013 17:47:38 +0000 6025892 at http://www.globalpost.com Patient 'progressing' after first artificial heart implant in France http://www.globalpost.com/dispatch/news/afp/131221/patient-progressing-after-first-artificial-heart-implant-france <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>A 75-year-old man who this week became the first person to receive an artificial heart developed by French biomedical firm Carmat was progressing well, doctors said Saturday.</p> <p>The patient was "progressing and recuperating", said surgeon Christian Latremouille, who was among the 16-strong team of doctors who performed the operation at the Georges Pompidou Hospital in Paris on Wednesday.</p> <p>Artificial hearts have already been in use for many years as a temporary fix for patients with chronic heart problems. </p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/131221/patient-progressing-after-first-artificial-heart-implant-france" target="_blank">read more</a></p> Cardiology Implants Medicine Technology AFP Sat, 21 Dec 2013 23:02:15 +0000 6026673 at http://www.globalpost.com Trial continues after patient death: French heartmaker http://www.globalpost.com/dispatch/news/afp/140304/trial-continues-after-patient-death-french-heartmaker <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>French biomedical firm Carmat said Tuesday it would implant its experimental artificial heart into another three people, as planned, after the first recipient died.</p> <p>In an email to AFP, the company said it was too soon to draw conclusions about the device's efficacy.</p> <p>A 76-year-old recipient died over the weekend, 75 days after receiving the gadget, whose trials are being closely followed by French investors.</p> <p>"It is premature to draw conclusions based on the outcomes from a single patient," said the the firm, whose stock was suspended at its own request on Tuesday.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2014.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/140304/trial-continues-after-patient-death-french-heartmaker" target="_blank">read more</a></p> Cardiology Health Implants Medicine AFP Tue, 04 Mar 2014 18:39:14 +0000 6086756 at http://www.globalpost.com Trial continues after patient death: French heartmaker http://www.globalpost.com/dispatch/news/afp/140304/trial-continues-after-patient-death-french-heartmaker-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>French biomedical firm Carmat said Tuesday it would implant its experimental artificial heart into another three people, as planned, after the first recipient died.</p> <p>In an email to AFP, the company said it was too soon to draw conclusions about the device's efficacy.</p> <p>A 76-year-old recipient died over the weekend, 75 days after receiving the gadget, whose trials are being closely followed by French investors.</p> <p>"It is premature to draw conclusions based on the outcomes from a single patient," said the the firm, whose stock was suspended at its own request on Tuesday.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2014.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/140304/trial-continues-after-patient-death-french-heartmaker-0" target="_blank">read more</a></p> Cardiology Health Implants Medicine AFP Tue, 04 Mar 2014 18:39:14 +0000 6086755 at http://www.globalpost.com Second artificial heart implant due in 'weeks': French heartmaker http://www.globalpost.com/dispatch/news/afp/140317/second-artificial-heart-implant-due-weeks-french-heartmaker <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>After its first recipient died, French biomedical firm Carmat said on Monday it expected to try again to implant its experimental artificial heart in another patient "in several weeks".</p> <p>Artificial hearts have been in use for many years as a temporary fix for patients with chronic heart problems, but the Carmat product aims to provide a longer-term solution to enable hospitalised patients to return home and lead normal lives.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2014.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/140317/second-artificial-heart-implant-due-weeks-french-heartmaker" target="_blank">read more</a></p> Cardiology Health Implants Medicine AFP Mon, 17 Mar 2014 14:04:09 +0000 6097655 at http://www.globalpost.com Artificial hearts can be a temporary fix http://www.globalpost.com/dispatch/news/afp/140327/artificial-hearts-can-be-temporary-fix <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>An artificial heart may help patients survive while awaiting a heart transplant, although the devices remain risky 10 years after they were approved, according to a US study Thursday.</p> <p>Researchers followed 22 patients with end-stage heart failure over the course of two months, to see how they responded to implantation with a Syncardia total artificial heart, the only such device that is approved by the US Food and Drug Administration.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2014.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/140327/artificial-hearts-can-be-temporary-fix" target="_blank">read more</a></p> Cardiology Health Implants Labor Medicine Social Issues AFP Thu, 27 Mar 2014 13:18:41 +0000 6106461 at http://www.globalpost.com